Epizyme reported $11.21M in Trade Debtors for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Debtors Change
Agios Pharmaceuticals AGIO:US $ 4.3M 1.6M
Amarin AMRN:US $ 143.94M 33.71M
Amgen AMGN:US $ 5327M 250M
Avrobio Inc AVRO:US 2.96M 116K
Biogen BIIB:US $ 2003.5M 17.9M
Cerulean Pharma CERU:US $ 1.73M 584.53K
Daiichi Sankyo 4568:JP Y 291037M 24362M
Eisai 4523:JP Y 198940M 9010M
Epizyme EPZM:US $ 11.21M 5.31M
Exelixis EXEL:US $ 235.4M 44.79M
Gilead Sciences GILD:US $ 4118M 331M
GlaxoSmithKline GSK:LN 6.87B 1.93B
Glaxosmithkline GSK:US $ 6870M 1927M
IONIS PHARMACEUT IONS:US $ 6.75M 19.37M
Karyopharm Therapeutics KPTI:US $ 23.48M 1.51M
Macrogenics MGNX:US $ 18.38M 3.48M
Mirati Therapeutics MRTX:US $ 1.53M 0.28M
Novartis NOVN:VX 8.91B 232M
Novartis NVS:US $ 8910M 232M
Regeneron Pharmaceuticals REGN:US $ 5161.4M 322.4M
Seattle Genetics SGEN:US $ 438.04M 37.03M
Spectrum Pharmaceuticals SPPI:US $ 0.61M 0.03M
Vertex Pharmaceuticals VRTX:US $ 1332.9M 40.1M
Xencor XNCR:US $ 54.28M 38.92M